Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 63% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
Alto Neuroscience Inc. (NYSE: ANRO) is a California-based biopharmaceutical company developing personalised treatments for mental health conditions. It focuses on innovative therapies for major depressive disorder (MDD), post-traumatic stress disorder (PTSD), and schizophrenia, with promising drug candidates like ALTO-100 and ALTO-300. The company is also pioneering a biomarker-based platform to tailor treatments, using patient-specific biological data to improve outcomes. Since its founding in 2019, Alto Neuroscience has been at the forefront of personalised mental health care.